Jade Biosciences
The Associate Director of Development Outsourcing supports the sourcing and strategic management of external vendors for clinical development programs from Phase I through Phase IV. This fully remote role partners with cross-functional teams to drive vendor execution, resolve issues, and improve outsourcing processes. The position requires occasional travel and involves managing vendor relationships, contracts, and governance activities.
Jade Biosciences is a clinical-stage biotechnology company on a mission to transform the standard of care for patients with autoimmune diseases. The company develops a pipeline of potentially best-in-class therapies built on discovery-stage assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. Its lead candidate, JADE101, is designed to inhibit the cytokine APRIL and is being developed for the treatment of immunoglobulin A nephropathy (IgAN).
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell
11 hours ago
Guggenheim raises Jade Biosciences stock price target on pipeline progress
1 day ago
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Jade Biosciences.
Jade Biosciences Announces $135 Million Private Placement
Oct 7, 2025
Associate Director, Outsourcing and Vendor Governance
Arcus Biosciences
Senior Director, Clinical Outsourcing
Eisai
Head of KYC Outsourcing Vendor Management
Wise
Sr Manager, Vendor Outsourcing
Gilead Sciences
Manager, Contingent Workforce Outsourcing (On-site)
Newrez LLC
Outsourcing Governance & Sourcing Manager
ANZ